[
  {
    "ts": null,
    "headline": "How Palantir—a company too small to make the Fortune 500—became one of the world’s 25 most valuable companies",
    "summary": "The company’s eccentric CEO has led one of the most controversial companies in Silicon Valley to unprecedented success.",
    "url": "https://finnhub.io/api/news?id=bfb8f689a5916c1412954b57ba6ea7ca2c35482e923c85b8c680d41596024894",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754523337,
      "headline": "How Palantir—a company too small to make the Fortune 500—became one of the world’s 25 most valuable companies",
      "id": 136246159,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The company’s eccentric CEO has led one of the most controversial companies in Silicon Valley to unprecedented success.",
      "url": "https://finnhub.io/api/news?id=bfb8f689a5916c1412954b57ba6ea7ca2c35482e923c85b8c680d41596024894"
    }
  },
  {
    "ts": null,
    "headline": "Tracking AMG's Yacktman Asset Management Portfolio - Q2 2025 Update",
    "summary": "Yacktman Asset Management's Q2 2025 13F portfolio value dipped slightly to $7.44B. Click here to read more about the portfolio.",
    "url": "https://finnhub.io/api/news?id=ae344ecced70e2cda893d90790bf5a019e1b642cb7dd3f9151fe58f474a67b0f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754521695,
      "headline": "Tracking AMG's Yacktman Asset Management Portfolio - Q2 2025 Update",
      "id": 136243808,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Yacktman Asset Management's Q2 2025 13F portfolio value dipped slightly to $7.44B. Click here to read more about the portfolio.",
      "url": "https://finnhub.io/api/news?id=ae344ecced70e2cda893d90790bf5a019e1b642cb7dd3f9151fe58f474a67b0f"
    }
  },
  {
    "ts": null,
    "headline": "Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029",
    "summary": "“Discover how advances in device technology and regional demand shifts are reshaping the future of medical aesthetics in BCC Research’s latest market analysis.”Boston, Aug. 06, 2025 (GLOBE NEWSWIRE) -- As global demand for aesthetic enhancement rises, medical aesthetic devices are transforming how patients approach cosmetic care. From laser-based treatments to minimally invasive procedures, leading companies such as AbbVie, Alma Lasers, and Johnson & Johnson to invest in next-generation technolo",
    "url": "https://finnhub.io/api/news?id=56967104105c5ef6f3aee82a6f98c7fa69f1198581f88ef77670f2001b6c7496",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754498040,
      "headline": "Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029",
      "id": 136238970,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "“Discover how advances in device technology and regional demand shifts are reshaping the future of medical aesthetics in BCC Research’s latest market analysis.”Boston, Aug. 06, 2025 (GLOBE NEWSWIRE) -- As global demand for aesthetic enhancement rises, medical aesthetic devices are transforming how patients approach cosmetic care. From laser-based treatments to minimally invasive procedures, leading companies such as AbbVie, Alma Lasers, and Johnson & Johnson to invest in next-generation technolo",
      "url": "https://finnhub.io/api/news?id=56967104105c5ef6f3aee82a6f98c7fa69f1198581f88ef77670f2001b6c7496"
    }
  },
  {
    "ts": null,
    "headline": "HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View",
    "summary": "Halozyme jumps 5.3% on second-quarter earnings and revenue beat, fueled by strong royalty growth, and a raised 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=e7c02bb9aa25879b5b7068561ffae321e550c1a398a3077e9863f664493ff7c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754495820,
      "headline": "HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View",
      "id": 136238971,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Halozyme jumps 5.3% on second-quarter earnings and revenue beat, fueled by strong royalty growth, and a raised 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=e7c02bb9aa25879b5b7068561ffae321e550c1a398a3077e9863f664493ff7c7"
    }
  },
  {
    "ts": null,
    "headline": "Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio",
    "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
    "url": "https://finnhub.io/api/news?id=84359879cd634f09fadcf68c57409f30e9801d04ab002d193a98b0fea7b6601b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754495103,
      "headline": "Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio",
      "id": 136238972,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
      "url": "https://finnhub.io/api/news?id=84359879cd634f09fadcf68c57409f30e9801d04ab002d193a98b0fea7b6601b"
    }
  },
  {
    "ts": null,
    "headline": "Bayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales View",
    "summary": "BAYRY beats on Q2 earnings and raises 2025 sales outlook (on a currency-adjusted basis) as pharma growth offsets currency and Xarelto headwinds.",
    "url": "https://finnhub.io/api/news?id=de5b7d45a4db9a6c8cb08bd3d16793ce27def554b411731e6de4617e5d20bc37",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754490780,
      "headline": "Bayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales View",
      "id": 136238346,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "BAYRY beats on Q2 earnings and raises 2025 sales outlook (on a currency-adjusted basis) as pharma growth offsets currency and Xarelto headwinds.",
      "url": "https://finnhub.io/api/news?id=de5b7d45a4db9a6c8cb08bd3d16793ce27def554b411731e6de4617e5d20bc37"
    }
  },
  {
    "ts": null,
    "headline": "8 Undervalued Stocks for a Rocky Market",
    "summary": "Companies that beat average analysts’ forecasts for both profit and revenue over the past two quarters and whose shares recently had price gains in response.",
    "url": "https://finnhub.io/api/news?id=23804efa59c9511b34eaa02f4f2d4141cb3dabc094be830300792b232ea95853",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754467200,
      "headline": "8 Undervalued Stocks for a Rocky Market",
      "id": 136232218,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Companies that beat average analysts’ forecasts for both profit and revenue over the past two quarters and whose shares recently had price gains in response.",
      "url": "https://finnhub.io/api/news?id=23804efa59c9511b34eaa02f4f2d4141cb3dabc094be830300792b232ea95853"
    }
  }
]